Showing results for all states.
A06.4 - Amebic liver abscess——
A15 - Respiratory tuberculosis——
A15.0 - Tuberculosis of lung——
A15.8 - Other respiratory tuberculosis——
A17 - Tuberculosis of nervous system——
A17.0 - Tuberculous meningitis——
A17.9 - Tuberculosis of nervous system, unspecified——
A18 - Tuberculosis of other organs——
A18.11 - Tuberculosis of kidney and ureter——
A18.31 - Tuberculous peritonitis——
A19 - Miliary tuberculosis——
A19.0 - Acute miliary tuberculosis of a single specified site——
A19.1 - Acute miliary tuberculosis of multiple sites——
A19.2 - Acute miliary tuberculosis, unspecified——
A19.8 - Other miliary tuberculosis——
A19.9 - Miliary tuberculosis, unspecified——
A31 - Infection due to other mycobacteria——
A31.0 - Pulmonary mycobacterial infection——
A41.9 - Sepsis, unspecified organism——
A49.01 - Methicillin susceptible Staphylococcus aureus infection, unspecified site——
A52.04 - Syphilitic cerebral arteritis——
A54.85 - Gonococcal peritonitis——
A69.22 - Other neurologic disorders in Lyme disease——
B00.81 - Herpesviral hepatitis——
B02.23 - Postherpetic polyneuropathy——
B02.9 - Zoster without complications——
B15 - Acute hepatitis A——
B15.0 - Hepatitis A with hepatic coma——
B15.9 - Hepatitis A without hepatic coma——
B16 - Acute hepatitis B——
B16.0 - Acute hepatitis B with delta-agent with hepatic coma——
B16.1 - Acute hepatitis B with delta-agent without hepatic coma——
B16.2 - Acute hepatitis B without delta-agent with hepatic coma——
B16.9 - Acute hepatitis B without delta-agent and without hepatic coma——
B17 - Other acute viral hepatitis——
B17.0 - Acute delta-(super) infection of hepatitis B carrier——
B17.1 - Acute hepatitis C——
B17.10 - Acute hepatitis C without hepatic coma——
B17.11 - Acute hepatitis C with hepatic coma——
B17.2 - Acute hepatitis E——
B17.8 - Other specified acute viral hepatitis——
B17.9 - Acute viral hepatitis, unspecified——
B18 - Chronic viral hepatitis——
B18.0 - Chronic viral hepatitis B with delta-agent——
B18.1 - Chronic viral hepatitis B without delta-agent——
B18.2 - Chronic viral hepatitis C——
B18.8 - Other chronic viral hepatitis——
B18.9 - Chronic viral hepatitis, unspecified——
B19 - Unspecified viral hepatitis——
B19.0 - Unspecified viral hepatitis with hepatic coma——
B19.1 - Unspecified viral hepatitis B——
B19.10 - Unspecified viral hepatitis B without hepatic coma——
B19.11 - Unspecified viral hepatitis B with hepatic coma——
B19.2 - Unspecified viral hepatitis C——
B19.20 - Unspecified viral hepatitis C without hepatic coma——
B19.21 - Unspecified viral hepatitis C with hepatic coma——
B19.9 - Unspecified viral hepatitis without hepatic coma——
B20 - Human immunodeficiency virus [HIV] disease——
B25 - Cytomegaloviral disease——
B25.1 - Cytomegaloviral hepatitis——
B25.9 - Cytomegaloviral disease, unspecified——
B26.81 - Mumps hepatitis——
B27 - Infectious mononucleosis——
B27.9 - Infectious mononucleosis, unspecified——
B34.9 - Viral infection, unspecified——
B37 - Candidiasis——
B37.9 - Candidiasis, unspecified——
B45.1 - Cerebral cryptococcosis——
B58.1 - Toxoplasma hepatitis——
B58.2 - Toxoplasma meningoencephalitis——
B59 - Pneumocystosis——
B65.9 - Schistosomiasis, unspecified——
B66.1 - Clonorchiasis——
B90 - Sequelae of tuberculosis——
B94.2 - Sequelae of viral hepatitis——
B95 - Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere——
B95.7 - Other staphylococcus as the cause of diseases classified elsewhere——
B97.35 - Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere——
C22 - Malignant neoplasm of liver and intrahepatic bile ducts——
C22.0 - Liver cell carcinoma——
C22.1 - Intrahepatic bile duct carcinoma——
C22.2 - Hepatoblastoma——
C22.3 - Angiosarcoma of liver——
C22.4 - Other sarcomas of liver——
C22.7 - Other specified carcinomas of liver——
C22.8 - Malignant neoplasm of liver, primary, unspecified as to type——
C22.9 - Malignant neoplasm of liver, not specified as primary or secondary——
C23 - Malignant neoplasm of gallbladder——
C24 - Malignant neoplasm of other and unspecified parts of biliary tract——
C24.0 - Malignant neoplasm of extrahepatic bile duct——
C24.1 - Malignant neoplasm of ampulla of Vater——
C24.8 - Malignant neoplasm of overlapping sites of biliary tract——
C24.9 - Malignant neoplasm of biliary tract, unspecified——
C25.0 - Malignant neoplasm of head of pancreas——
C46 - Kaposi's sarcoma——
C46.9 - Kaposi's sarcoma, unspecified——
C64 - Malignant neoplasm of kidney, except renal pelvis——
C77 - Secondary and unspecified malignant neoplasm of lymph nodes——
C77.0 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck——
C77.2 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes——
C77.8 - Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions——
C77.9 - Secondary and unspecified malignant neoplasm of lymph node, unspecified——
C78.6 - Secondary malignant neoplasm of retroperitoneum and peritoneum——
C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct——
C78.8 - Secondary malignant neoplasm of other and unspecified digestive organs——
C79 - Secondary malignant neoplasm of other and unspecified sites——
C79.51 - Secondary malignant neoplasm of bone——
C79.52 - Secondary malignant neoplasm of bone marrow——
C79.9 - Secondary malignant neoplasm of unspecified site——
C81 - Hodgkin lymphoma——
C81.0 - Nodular lymphocyte predominant Hodgkin lymphoma——
C81.00 - Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site——
C81.01 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.02 - Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes——
C81.03 - Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.06 - Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes——
C81.07 - Nodular lymphocyte predominant Hodgkin lymphoma, spleen——
C81.08 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites——
C81.09 - Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites——
C81.1 - Nodular sclerosis Hodgkin lymphoma——
C81.10 - Nodular sclerosis Hodgkin lymphoma, unspecified site——
C81.11 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.12 - Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes——
C81.13 - Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.16 - Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes——
C81.17 - Nodular sclerosis Hodgkin lymphoma, spleen——
C81.18 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites——
C81.2 - Mixed cellularity Hodgkin lymphoma——
C81.20 - Mixed cellularity Hodgkin lymphoma, unspecified site——
C81.21 - Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.22 - Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes——
C81.23 - Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.24 - Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb——
C81.25 - Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb——
C81.26 - Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes——
C81.27 - Mixed cellularity Hodgkin lymphoma, spleen——
C81.28 - Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites——
C81.29 - Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites——
C82 - Follicular lymphoma——
C82.0 - Follicular lymphoma grade I——
C82.00 - Follicular lymphoma grade I, unspecified site——
C82.01 - Follicular lymphoma grade I, lymph nodes of head, face, and neck——
C82.02 - Follicular lymphoma grade I, intrathoracic lymph nodes——
C82.07 - Follicular lymphoma grade I, spleen——
C82.0A - Follicular lymphoma grade I, in remission——
C82.1 - Follicular lymphoma grade II——
C82.10 - Follicular lymphoma grade II, unspecified site——
C82.11 - Follicular lymphoma grade II, lymph nodes of head, face, and neck——
C82.17 - Follicular lymphoma grade II, spleen——
C82.30 - Follicular lymphoma grade IIIa, unspecified site——
C82.31 - Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck——
C82.32 - Follicular lymphoma grade IIIa, intrathoracic lymph nodes——
C82.37 - Follicular lymphoma grade IIIa, spleen——
C82.4 - Follicular lymphoma grade IIIb——
C82.89 - Other types of follicular lymphoma, extranodal and solid organ sites——
C82.90 - Follicular lymphoma, unspecified, unspecified site——
C82.99 - Follicular lymphoma, unspecified, extranodal and solid organ sites——
C83 - Non-follicular lymphoma——
C83.0 - Small cell B-cell lymphoma——
C83.00 - Small cell B-cell lymphoma, unspecified site——
C83.1 - Mantle cell lymphoma——
C83.10 - Mantle cell lymphoma, unspecified site——
C83.11 - Mantle cell lymphoma, lymph nodes of head, face, and neck——
C83.12 - Mantle cell lymphoma, intrathoracic lymph nodes——
C83.13 - Mantle cell lymphoma, intra-abdominal lymph nodes——
C83.14 - Mantle cell lymphoma, lymph nodes of axilla and upper limb——
C83.15 - Mantle cell lymphoma, lymph nodes of inguinal region and lower limb——
C83.16 - Mantle cell lymphoma, intrapelvic lymph nodes——
C83.17 - Mantle cell lymphoma, spleen——
C83.18 - Mantle cell lymphoma, lymph nodes of multiple sites——
C83.19 - Mantle cell lymphoma, extranodal and solid organ sites——
C83.1A - Mantle cell lymphoma, in remission——
C83.3 - Diffuse large B-cell lymphoma——
C83.30 - Diffuse large B-cell lymphoma, unspecified site——
C83.31 - Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck——
C83.32 - Diffuse large B-cell lymphoma, intrathoracic lymph nodes——
C83.33 - Diffuse large B-cell lymphoma, intra-abdominal lymph nodes——
C83.34 - Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb——
C83.35 - Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb——
C83.36 - Diffuse large B-cell lymphoma, intrapelvic lymph nodes——
C83.37 - Diffuse large B-cell lymphoma, spleen——
C83.38 - Diffuse large B-cell lymphoma, lymph nodes of multiple sites——
C83.39 - Diffuse large B-cell lymphoma, extranodal and solid organ sites——
C83.390 - Primary central nervous system lymphoma——
C83.3A - Diffuse large B-cell lymphoma, in remission——
C84 - Mature T/NK-cell lymphomas——
C84.6 - Anaplastic large cell lymphoma, ALK-positive——
C84.70 - Anaplastic large cell lymphoma, ALK-negative, unspecified site——
C84.71 - Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck——
C84.9 - Mature T/NK-cell lymphomas, unspecified——
C85 - Other specified and unspecified types of non-Hodgkin lymphoma——
C85.1 - Unspecified B-cell lymphoma——
C85.10 - Unspecified B-cell lymphoma, unspecified site——
C85.2 - Mediastinal (thymic) large B-cell lymphoma——
C85.20 - Mediastinal (thymic) large B-cell lymphoma, unspecified site——
C85.27 - Mediastinal (thymic) large B-cell lymphoma, spleen——
C85.8 - Other specified types of non-Hodgkin lymphoma——
C85.80 - Other specified types of non-Hodgkin lymphoma, unspecified site——
C85.86 - Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes——
C85.89 - Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites——
C85.9 - Non-Hodgkin lymphoma, unspecified——
C85.90 - Non-Hodgkin lymphoma, unspecified, unspecified site——
C85.91 - Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck——
C85.92 - Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes——
C85.93 - Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes——
C85.94 - Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb——
C85.95 - Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb——
C85.96 - Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes——
C85.97 - Non-Hodgkin lymphoma, unspecified, spleen——
C85.98 - Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites——
C85.99 - Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites——
C86 - Other specified types of T/NK-cell lymphoma——
C88 - Malignant immunoproliferative diseases and certain other B-cell lymphomas——
C88.0 - Waldenstrom macroglobulinemia——
C88.00 - Waldenstrom macroglobulinemia not having achieved remission——
C88.2 - Heavy chain disease——
C88.9 - Malignant immunoproliferative disease, unspecified——
C90 - Multiple myeloma and malignant plasma cell neoplasms——
C90.0 - Multiple myeloma——
C90.00 - Multiple myeloma not having achieved remission——
C91.10 - Chronic lymphocytic leukemia of B-cell type not having achieved remission——
C91.50 - Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission——
D01.5 - Carcinoma in situ of liver, gallbladder and bile ducts——
D13 - Benign neoplasm of other and ill-defined parts of digestive system——
D13.4 - Benign neoplasm of liver——
D13.5 - Benign neoplasm of extrahepatic bile ducts——
D18 - Hemangioma and lymphangioma, any site——
D18.09 - Hemangioma of other sites——
D37 - Neoplasm of uncertain behavior of oral cavity and digestive organs——
D37.1 - Neoplasm of uncertain behavior of stomach——
D37.6 - Neoplasm of uncertain behavior of liver, gallbladder and bile ducts——
D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified——
D47.2 - Monoclonal gammopathy——
D51 - Vitamin B12 deficiency anemia——
D51.9 - Vitamin B12 deficiency anemia, unspecified——
D52 - Folate deficiency anemia——
D52.9 - Folate deficiency anemia, unspecified——
D55 - Anemia due to enzyme disorders——
D55.0 - Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency——
D57.1 - Sickle-cell disease without crisis——
D58 - Other hereditary hemolytic anemias——
D58.9 - Hereditary hemolytic anemia, unspecified——
D59 - Acquired hemolytic anemia——
D59.0 - Drug-induced autoimmune hemolytic anemia——
D59.10 - Autoimmune hemolytic anemia, unspecified——
D59.11 - Warm autoimmune hemolytic anemia——
D59.2 - Drug-induced nonautoimmune hemolytic anemia——
D59.3 - Hemolytic-uremic syndrome——
D59.39 - Other hemolytic-uremic syndrome——
D59.9 - Acquired hemolytic anemia, unspecified——
D61 - Other aplastic anemias and other bone marrow failure syndromes——
D61.8 - Other specified aplastic anemias and other bone marrow failure syndromes——
D61.81 - Pancytopenia——
D61.810 - Antineoplastic chemotherapy induced pancytopenia——
D61.818 - Other pancytopenia——
D61.9 - Aplastic anemia, unspecified——
D62 - Acute posthemorrhagic anemia——
D63 - Anemia in chronic diseases classified elsewhere——
D63.1 - Anemia in chronic kidney disease——
D64 - Other anemias——
D64.9 - Anemia, unspecified——
D65 - Disseminated intravascular coagulation [defibrination syndrome]——
D68 - Other coagulation defects——
D68.9 - Coagulation defect, unspecified——
D69 - Purpura and other hemorrhagic conditions——
D69.0 - Allergic purpura——
D69.3 - Immune thrombocytopenic purpura——
D69.4 - Other primary thrombocytopenia——
D69.59 - Other secondary thrombocytopenia——
D69.6 - Thrombocytopenia, unspecified——
D69.8 - Other specified hemorrhagic conditions——
D70 - Neutropenia——
D70.9 - Neutropenia, unspecified——
D84 - Other immunodeficiencies——
D84.9 - Immunodeficiency, unspecified——
D89 - Other disorders involving the immune mechanism, not elsewhere classified——
D89.0 - Polyclonal hypergammaglobulinemia——
D89.1 - Cryoglobulinemia——
D89.2 - Hypergammaglobulinemia, unspecified——
D89.81 - Graft-versus-host disease——
D89.9 - Disorder involving the immune mechanism, unspecified——
E08.22 - Diabetes mellitus due to underlying condition with diabetic chronic kidney disease——
E08.29 - Diabetes mellitus due to underlying condition with other diabetic kidney complication——
E09.22 - Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease——
E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease——
E10.29 - Type 1 diabetes mellitus with other diabetic kidney complication——
E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy——
E10.65 - Type 1 diabetes mellitus with hyperglycemia——
E11.21 - Type 2 diabetes mellitus with diabetic nephropathy——
E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease——
E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication——
E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified——
E11.41 - Type 2 diabetes mellitus with diabetic mononeuropathy——
E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy——
E11.43 - Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy——
E11.65 - Type 2 diabetes mellitus with hyperglycemia——
E11.9 - Type 2 diabetes mellitus without complications——
E13.2 - Other specified diabetes mellitus with kidney complications——
E13.22 - Other specified diabetes mellitus with diabetic chronic kidney disease——
E13.29 - Other specified diabetes mellitus with other diabetic kidney complication——
E16.2 - Hypoglycemia, unspecified——
E27.1 - Primary adrenocortical insufficiency——
E43 - Unspecified severe protein-calorie malnutrition——
E51 - Thiamine deficiency——
E51.9 - Thiamine deficiency, unspecified——
E53 - Deficiency of other B group vitamins——
E53.8 - Deficiency of other specified B group vitamins——
E55.9 - Vitamin D deficiency, unspecified——
E56 - Other vitamin deficiencies——
E56.1 - Deficiency of vitamin K——
E66 - Overweight and obesity——
E66.811 - Obesity, class 1——
E66.9 - Obesity, unspecified——
E71.522 - Adrenomyeloneuropathy——
E74.01 - von Gierke disease——
E75.5 - Other lipid storage disorders——
E78 - Disorders of lipoprotein metabolism and other lipidemias——
E78.1 - Pure hyperglyceridemia——
E78.3 - Hyperchylomicronemia——
E78.49 - Other hyperlipidemia——
E78.5 - Hyperlipidemia, unspecified——
E79.0 - Hyperuricemia without signs of inflammatory arthritis and tophaceous disease——
E80 - Disorders of porphyrin and bilirubin metabolism——
E80.4 - Gilbert syndrome——
E80.5 - Crigler-Najjar syndrome——
E83.01 - Wilson's disease——
E83.11 - Hemochromatosis——
E83.110 - Hereditary hemochromatosis——
E83.118 - Other hemochromatosis——
E83.119 - Hemochromatosis, unspecified——
E83.39 - Other disorders of phosphorus metabolism——
E85.1 - Neuropathic heredofamilial amyloidosis——
E87.1 - Hypo-osmolality and hyponatremia——
E87.2 - Acidosis——
E87.20 - Acidosis, unspecified——
E87.5 - Hyperkalemia——
E88.09 - Other disorders of plasma-protein metabolism, not elsewhere classified——
E88.3 - Tumor lysis syndrome——
E88.810 - Metabolic syndrome——
F10 - Alcohol related disorders——
F10.1 - Alcohol abuse——
F10.10 - Alcohol abuse, uncomplicated——
F10.11 - Alcohol abuse, in remission——
F10.12 - Alcohol abuse with intoxication——
F10.13 - Alcohol abuse, with withdrawal——
F10.188 - Alcohol abuse with other alcohol-induced disorder——
F10.2 - Alcohol dependence——
F10.20 - Alcohol dependence, uncomplicated——
F10.21 - Alcohol dependence, in remission——
F10.221 - Alcohol dependence with intoxication delirium——
F10.229 - Alcohol dependence with intoxication, unspecified——
F10.23 - Alcohol dependence with withdrawal——
F10.230 - Alcohol dependence with withdrawal, uncomplicated——
F10.288 - Alcohol dependence with other alcohol-induced disorder——
F10.90 - Alcohol use, unspecified, uncomplicated——
F11 - Opioid related disorders——
F11.1 - Opioid abuse——
F11.10 - Opioid abuse, uncomplicated——
F11.11 - Opioid abuse, in remission——
F11.12 - Opioid abuse with intoxication——
F11.2 - Opioid dependence——
F11.20 - Opioid dependence, uncomplicated——
F11.21 - Opioid dependence, in remission——
F11.22 - Opioid dependence with intoxication——
F11.29 - Opioid dependence with unspecified opioid-induced disorder——
F11.9 - Opioid use, unspecified——
F11.90 - Opioid use, unspecified, uncomplicated——
F11.91 - Opioid use, unspecified, in remission——
F11.92 - Opioid use, unspecified with intoxication——
F12 - Cannabis related disorders——
F12.1 - Cannabis abuse——
F12.11 - Cannabis abuse, in remission——
F12.12 - Cannabis abuse with intoxication——
F12.120 - Cannabis abuse with intoxication, uncomplicated——
F13 - Sedative, hypnotic, or anxiolytic related disorders——
F13.1 - Sedative, hypnotic or anxiolytic-related abuse——
F13.10 - Sedative, hypnotic or anxiolytic abuse, uncomplicated——
F14 - Cocaine related disorders——
F14.1 - Cocaine abuse——
F14.10 - Cocaine abuse, uncomplicated——
F14.11 - Cocaine abuse, in remission——
F14.12 - Cocaine abuse with intoxication——
F14.120 - Cocaine abuse with intoxication, uncomplicated——
F14.2 - Cocaine dependence——
F14.20 - Cocaine dependence, uncomplicated——
F14.23 - Cocaine dependence with withdrawal——
F15 - Other stimulant related disorders——
F15.1 - Other stimulant abuse——
F15.10 - Other stimulant abuse, uncomplicated——
F16 - Hallucinogen related disorders——
F16.1 - Hallucinogen abuse——
F16.10 - Hallucinogen abuse, uncomplicated——
F16.11 - Hallucinogen abuse, in remission——
F16.2 - Hallucinogen dependence——
F16.20 - Hallucinogen dependence, uncomplicated——
F17.2 - Nicotine dependence——
F18 - Inhalant related disorders——
F18.1 - Inhalant abuse——
F18.10 - Inhalant abuse, uncomplicated——
F18.2 - Inhalant dependence——
F18.20 - Inhalant dependence, uncomplicated——
F18.21 - Inhalant dependence, in remission——
F18.22 - Inhalant dependence with intoxication——
F19 - Other psychoactive substance related disorders——
F19.1 - Other psychoactive substance abuse——
F19.10 - Other psychoactive substance abuse, uncomplicated——
F19.11 - Other psychoactive substance abuse, in remission——
F19.12 - Other psychoactive substance abuse with intoxication——
F19.2 - Other psychoactive substance dependence——
F19.20 - Other psychoactive substance dependence, uncomplicated——
F19.9 - Other psychoactive substance use, unspecified——
F20.9 - Schizophrenia, unspecified——
F31.9 - Bipolar disorder, unspecified——
F32 - Depressive episode——
F32.9 - Major depressive disorder, single episode, unspecified——
F32.A - Depression, unspecified——
F41 - Other anxiety disorders——
F41.9 - Anxiety disorder, unspecified——
F43.10 - Post-traumatic stress disorder, unspecified——
F55 - Abuse of non-psychoactive substances——
G13.0 - Paraneoplastic neuromyopathy and neuropathy——
G40.509 - Epileptic seizures related to external causes, not intractable, without status epilepticus——
G58 - Other mononeuropathies——
G58.9 - Mononeuropathy, unspecified——
G60 - Hereditary and idiopathic neuropathy——
G60.0 - Hereditary motor and sensory neuropathy——
G60.2 - Neuropathy in association with hereditary ataxia——
G60.3 - Idiopathic progressive neuropathy——
G60.8 - Other hereditary and idiopathic neuropathies——
G60.9 - Hereditary and idiopathic neuropathy, unspecified——
G61 - Inflammatory polyneuropathy——
G61.0 - Guillain-Barre syndrome——
G61.1 - Serum neuropathy——
G61.81 - Chronic inflammatory demyelinating polyneuritis——
G61.82 - Multifocal motor neuropathy——
G61.89 - Other inflammatory polyneuropathies——
G61.9 - Inflammatory polyneuropathy, unspecified——
G62 - Other and unspecified polyneuropathies——
G62.0 - Drug-induced polyneuropathy——
G62.1 - Alcoholic polyneuropathy——
G62.8 - Other specified polyneuropathies——
G62.81 - Critical illness polyneuropathy——
G62.89 - Other specified polyneuropathies——
G62.9 - Polyneuropathy, unspecified——
G63 - Polyneuropathy in diseases classified elsewhere——
G65.0 - Sequelae of Guillain-Barre syndrome——
G65.2 - Sequelae of toxic polyneuropathy——
G89 - Pain, not elsewhere classified——
G89.29 - Other chronic pain——
G89.3 - Neoplasm related pain (acute) (chronic)——
G89.4 - Chronic pain syndrome——
G90.0 - Idiopathic peripheral autonomic neuropathy——
G90.09 - Other idiopathic peripheral autonomic neuropathy——
G90.3 - Multi-system degeneration of the autonomic nervous system——
G90.9 - Disorder of the autonomic nervous system, unspecified——
G93.40 - Encephalopathy, unspecified——
G93.49 - Other encephalopathy——
G93.6 - Cerebral edema——
G99 - Other disorders of nervous system in diseases classified elsewhere——
G99.0 - Autonomic neuropathy in diseases classified elsewhere——
H15.0 - Scleritis——
H20.9 - Unspecified iridocyclitis——
H34.10 - Central retinal artery occlusion, unspecified eye——
H54.7 - Unspecified visual loss——
H73.019 - Bullous myringitis, unspecified ear——
I10 - Essential (primary) hypertension——
I12 - Hypertensive chronic kidney disease——
I12.0 - Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease——
I12.9 - Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease——
I13 - Hypertensive heart and chronic kidney disease——
I13.1 - Hypertensive heart and chronic kidney disease without heart failure——
I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris——
I30 - Acute pericarditis——
I30.1 - Infective pericarditis——
I31.3 - Pericardial effusion (noninflammatory)——
I31.9 - Disease of pericardium, unspecified——
I33.0 - Acute and subacute infective endocarditis——
I40 - Acute myocarditis——
I40.9 - Acute myocarditis, unspecified——
I42.0 - Dilated cardiomyopathy——
I42.6 - Alcoholic cardiomyopathy——
I48.91 - Unspecified atrial fibrillation——
I50.22 - Chronic systolic (congestive) heart failure——
I50.9 - Heart failure, unspecified——
I61 - Nontraumatic intracerebral hemorrhage——
I61.9 - Nontraumatic intracerebral hemorrhage, unspecified——
I63 - Cerebral infarction——
I63.9 - Cerebral infarction, unspecified——
I67.7 - Cerebral arteritis, not elsewhere classified——
I68.2 - Cerebral arteritis in other diseases classified elsewhere——
I71 - Aortic aneurysm and dissection——
I71.9 - Aortic aneurysm of unspecified site, without rupture——
I72.9 - Aneurysm of unspecified site——
I73.00 - Raynaud's syndrome without gangrene——
I74.9 - Embolism and thrombosis of unspecified artery——
I77 - Other disorders of arteries and arterioles——
I77.6 - Arteritis, unspecified——
I77.89 - Other specified disorders of arteries and arterioles——
I81 - Portal vein thrombosis——
I82 - Other venous embolism and thrombosis——
I82.0 - Budd-Chiari syndrome——
I82.409 - Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity——
I85 - Esophageal varices——
I85.0 - Esophageal varices——
I85.00 - Esophageal varices without bleeding——
I95 - Hypotension——
I95.9 - Hypotension, unspecified——
J18.9 - Pneumonia, unspecified organism——
J32.9 - Chronic sinusitis, unspecified——
J33 - Nasal polyp——
J33.9 - Nasal polyp, unspecified——
J45 - Asthma——
J45.901 - Unspecified asthma with (acute) exacerbation——
J70.2 - Acute drug-induced interstitial lung disorders——
J80 - Acute respiratory distress syndrome——
J84 - Other interstitial pulmonary diseases——
J84.116 - Cryptogenic organizing pneumonia——
J84.9 - Interstitial pulmonary disease, unspecified——
J96.01 - Acute respiratory failure with hypoxia——
J98 - Other respiratory disorders——
J98.0 - Diseases of bronchus, not elsewhere classified——
J98.09 - Other diseases of bronchus, not elsewhere classified——
J98.4 - Other disorders of lung——
K29.20 - Alcoholic gastritis without bleeding——
K50.90 - Crohn's disease, unspecified, without complications——
K52.9 - Noninfective gastroenteritis and colitis, unspecified——
K55.0 - Acute vascular disorders of intestine——
K55.9 - Vascular disorder of intestine, unspecified——
K65 - Peritonitis——
K65.1 - Peritoneal abscess——
K65.2 - Spontaneous bacterial peritonitis——
K65.9 - Peritonitis, unspecified——
K70 - Alcoholic liver disease——
K70.0 - Alcoholic fatty liver——
K70.1 - Alcoholic hepatitis——
K70.10 - Alcoholic hepatitis without ascites——
K70.11 - Alcoholic hepatitis with ascites——
K70.2 - Alcoholic fibrosis and sclerosis of liver——
K70.3 - Alcoholic cirrhosis of liver——
K70.30 - Alcoholic cirrhosis of liver without ascites——
K70.31 - Alcoholic cirrhosis of liver with ascites——
K70.4 - Alcoholic hepatic failure——
K70.40 - Alcoholic hepatic failure without coma——
K70.41 - Alcoholic hepatic failure with coma——
K70.9 - Alcoholic liver disease, unspecified——
K71 - Toxic liver disease——
K71.0 - Toxic liver disease with cholestasis——
K71.1 - Toxic liver disease with hepatic necrosis——
K71.10 - Toxic liver disease with hepatic necrosis, without coma——
K71.11 - Toxic liver disease with hepatic necrosis, with coma——
K71.2 - Toxic liver disease with acute hepatitis——
K71.3 - Toxic liver disease with chronic persistent hepatitis——
K71.5 - Toxic liver disease with chronic active hepatitis——
K71.6 - Toxic liver disease with hepatitis, not elsewhere classified——
K71.9 - Toxic liver disease, unspecified——
K72 - Hepatic failure, not elsewhere classified——
K72.0 - Acute and subacute hepatic failure——
K72.00 - Acute and subacute hepatic failure without coma——
K72.01 - Acute and subacute hepatic failure with coma——
K72.1 - Chronic hepatic failure——
K72.10 - Chronic hepatic failure without coma——
K72.11 - Chronic hepatic failure with coma——
K72.9 - Hepatic failure, unspecified——
K72.90 - Hepatic failure, unspecified without coma——
K72.91 - Hepatic failure, unspecified with coma——
K73 - Chronic hepatitis, not elsewhere classified——
K73.9 - Chronic hepatitis, unspecified——
K74 - Fibrosis and cirrhosis of liver——
K74.0 - Hepatic fibrosis——
K74.00 - Hepatic fibrosis, unspecified——
K74.01 - Hepatic fibrosis, early fibrosis——
K74.3 - Primary biliary cirrhosis——
K74.4 - Secondary biliary cirrhosis——
K74.5 - Biliary cirrhosis, unspecified——
K74.6 - Other and unspecified cirrhosis of liver——
K74.60 - Unspecified cirrhosis of liver——
K74.69 - Other cirrhosis of liver——
K75 - Other inflammatory liver diseases——
K75.0 - Abscess of liver——
K75.2 - Nonspecific reactive hepatitis——
K75.4 - Autoimmune hepatitis——
K75.8 - Other specified inflammatory liver diseases——
K75.81 - Nonalcoholic steatohepatitis (NASH)——
K75.89 - Other specified inflammatory liver diseases——
K75.9 - Inflammatory liver disease, unspecified——
K76 - Other diseases of liver——
K76.0 - Fatty (change of) liver, not elsewhere classified——
K76.1 - Chronic passive congestion of liver——
K76.2 - Central hemorrhagic necrosis of liver——
K76.3 - Infarction of liver——
K76.5 - Hepatic veno-occlusive disease——
K76.6 - Portal hypertension——
K76.7 - Hepatorenal syndrome——
K76.8 - Other specified diseases of liver——
K76.82 - Hepatic encephalopathy——
K76.89 - Other specified diseases of liver——
K76.9 - Liver disease, unspecified——
K77 - Liver disorders in diseases classified elsewhere——
K80 - Cholelithiasis——
K80.50 - Calculus of bile duct without cholangitis or cholecystitis without obstruction——
K83 - Other diseases of biliary tract——
K83.0 - Cholangitis——
K83.01 - Primary sclerosing cholangitis——
K83.09 - Other cholangitis——
K83.1 - Obstruction of bile duct——
K83.5 - Biliary cyst——
K86.0 - Alcohol-induced chronic pancreatitis——
K87 - Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere——
K91.5 - Postcholecystectomy syndrome——
K92.1 - Melena——
K92.2 - Gastrointestinal hemorrhage, unspecified——
L03.90 - Cellulitis, unspecified——
L40.9 - Psoriasis, unspecified——
L50.9 - Urticaria, unspecified——
L93 - Lupus erythematosus——
L93.0 - Discoid lupus erythematosus——
L93.1 - Subacute cutaneous lupus erythematosus——
L93.2 - Other local lupus erythematosus——
L95 - Vasculitis limited to skin, not elsewhere classified——
L95.0 - Livedoid vasculitis——
L95.1 - Erythema elevatum diutinum——
L95.8 - Other vasculitis limited to the skin——
L95.9 - Vasculitis limited to the skin, unspecified——
L98.499 - Non-pressure chronic ulcer of skin of other sites with unspecified severity——
M05 - Rheumatoid arthritis with rheumatoid factor——
M05.2 - Rheumatoid vasculitis with rheumatoid arthritis——
M05.20 - Rheumatoid vasculitis with rheumatoid arthritis of unspecified site——
M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis——
M05.79 - Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement——
M06.9 - Rheumatoid arthritis, unspecified——
M13.0 - Polyarthritis, unspecified——
M25 - Other joint disorder, not elsewhere classified——
M25.48 - Effusion, other site——
M25.5 - Pain in joint——
M25.50 - Pain in unspecified joint——
M30 - Polyarteritis nodosa and related conditions——
M30.0 - Polyarteritis nodosa——
M30.1 - Polyarteritis with lung involvement [Churg-Strauss]——
M30.2 - Juvenile polyarteritis——
M30.3 - Mucocutaneous lymph node syndrome [Kawasaki]——
M30.8 - Other conditions related to polyarteritis nodosa——
M31 - Other necrotizing vasculopathies——
M31.0 - Hypersensitivity angiitis——
M31.1 - Thrombotic microangiopathy——
M31.19 - Other thrombotic microangiopathy——
M31.3 - Wegener's granulomatosis——
M31.30 - Wegener's granulomatosis without renal involvement——
M31.31 - Wegener's granulomatosis with renal involvement——
M31.4 - Aortic arch syndrome [Takayasu]——
M31.5 - Giant cell arteritis with polymyalgia rheumatica——
M31.6 - Other giant cell arteritis——
M31.7 - Microscopic polyangiitis——
M31.8 - Other specified necrotizing vasculopathies——
M31.9 - Necrotizing vasculopathy, unspecified——
M32 - Systemic lupus erythematosus (SLE)——
M32.0 - Drug-induced systemic lupus erythematosus——
M32.1 - Systemic lupus erythematosus with organ or system involvement——
M32.10 - Systemic lupus erythematosus, organ or system involvement unspecified——
M32.11 - Endocarditis in systemic lupus erythematosus——
M32.12 - Pericarditis in systemic lupus erythematosus——
M32.13 - Lung involvement in systemic lupus erythematosus——
M32.14 - Glomerular disease in systemic lupus erythematosus——
M32.15 - Tubulo-interstitial nephropathy in systemic lupus erythematosus——
M32.19 - Other organ or system involvement in systemic lupus erythematosus——
M32.8 - Other forms of systemic lupus erythematosus——
M32.9 - Systemic lupus erythematosus, unspecified——
M35 - Other systemic involvement of connective tissue——
M35.00 - Sjogren syndrome, unspecified——
M35.1 - Other overlap syndromes——
M35.3 - Polymyalgia rheumatica——
M35.9 - Systemic involvement of connective tissue, unspecified——
M79.10 - Myalgia, unspecified site——
M79.2 - Neuralgia and neuritis, unspecified——
M79.3 - Panniculitis, unspecified——
N00 - Acute nephritic syndrome——
N00.0 - Acute nephritic syndrome with minor glomerular abnormality——
N00.1 - Acute nephritic syndrome with focal and segmental glomerular lesions——
N00.2 - Acute nephritic syndrome with diffuse membranous glomerulonephritis——
N00.3 - Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis——
N00.4 - Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis——
N00.5 - Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis——
N00.6 - Acute nephritic syndrome with dense deposit disease——
N00.7 - Acute nephritic syndrome with diffuse crescentic glomerulonephritis——
N00.8 - Acute nephritic syndrome with other morphologic changes——
N00.9 - Acute nephritic syndrome with unspecified morphologic changes——
N00.A - Acute nephritic syndrome with C3 glomerulonephritis——
N01 - Rapidly progressive nephritic syndrome——
N01.0 - Rapidly progressive nephritic syndrome with minor glomerular abnormality——
N01.1 - Rapidly progressive nephritic syndrome with focal and segmental glomerular lesions——
N01.2 - Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis——
N01.6 - Rapidly progressive nephritic syndrome with dense deposit disease——
N02 - Recurrent and persistent hematuria——
N02.0 - Recurrent and persistent hematuria with minor glomerular abnormality——
N02.2 - Recurrent and persistent hematuria with diffuse membranous glomerulonephritis——
N02.8 - Recurrent and persistent hematuria with other morphologic changes——
N02.A - Recurrent and persistent hematuria with C3 glomerulonephritis——
N02.B3 - Recurrent and persistent immunoglobulin A nephropathy with diffuse membranoproliferative glomerulonephritis——
N03 - Chronic nephritic syndrome——
N03.0 - Chronic nephritic syndrome with minor glomerular abnormality——
N03.1 - Chronic nephritic syndrome with focal and segmental glomerular lesions——
N03.2 - Chronic nephritic syndrome with diffuse membranous glomerulonephritis——
N03.3 - Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis——
N03.4 - Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis——
N03.5 - Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis——
N03.6 - Chronic nephritic syndrome with dense deposit disease——
N03.7 - Chronic nephritic syndrome with diffuse crescentic glomerulonephritis——
N03.9 - Chronic nephritic syndrome with unspecified morphologic changes——
N03.A - Chronic nephritic syndrome with C3 glomerulonephritis——
N04 - Nephrotic syndrome——
N04.0 - Nephrotic syndrome with minor glomerular abnormality——
N04.1 - Nephrotic syndrome with focal and segmental glomerular lesions——
N04.2 - Nephrotic syndrome with diffuse membranous glomerulonephritis——
N04.20 - Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified——
N04.3 - Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis——
N04.4 - Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis——
N04.5 - Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis——
N04.6 - Nephrotic syndrome with dense deposit disease——
N04.8 - Nephrotic syndrome with other morphologic changes——
N04.9 - Nephrotic syndrome with unspecified morphologic changes——
N05 - Unspecified nephritic syndrome——
N05.0 - Unspecified nephritic syndrome with minor glomerular abnormality——
N05.1 - Unspecified nephritic syndrome with focal and segmental glomerular lesions——
N05.2 - Unspecified nephritic syndrome with diffuse membranous glomerulonephritis——
N05.4 - Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis——
N05.5 - Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis——
N05.6 - Unspecified nephritic syndrome with dense deposit disease——
N06 - Isolated proteinuria with specified morphological lesion——
N06.0 - Isolated proteinuria with minor glomerular abnormality——
N06.1 - Isolated proteinuria with focal and segmental glomerular lesions——
N06.2 - Isolated proteinuria with diffuse membranous glomerulonephritis——
N06.20 - Isolated proteinuria with diffuse membranous glomerulonephritis, unspecified——
N08 - Glomerular disorders in diseases classified elsewhere——
N11.9 - Chronic tubulo-interstitial nephritis, unspecified——
N13 - Obstructive and reflux uropathy——
N16 - Renal tubulo-interstitial disorders in diseases classified elsewhere——
N17 - Acute kidney failure——
N17.9 - Acute kidney failure, unspecified——
N18 - Chronic kidney disease (CKD)——
N18.1 - Chronic kidney disease, stage 1——
N18.2 - Chronic kidney disease, stage 2 (mild)——
N18.3 - Chronic kidney disease, stage 3 (moderate)——
N18.31 - Chronic kidney disease, stage 3a——
N18.6 - End stage renal disease——
N18.9 - Chronic kidney disease, unspecified——
N23 - Unspecified renal colic——
N25.81 - Secondary hyperparathyroidism of renal origin——
N26 - Unspecified contracted kidney——
N26.9 - Renal sclerosis, unspecified——
N28 - Other disorders of kidney and ureter, not elsewhere classified——
N28.9 - Disorder of kidney and ureter, unspecified——
N31 - Neuromuscular dysfunction of bladder, not elsewhere classified——
N31.8 - Other neuromuscular dysfunction of bladder——
N31.9 - Neuromuscular dysfunction of bladder, unspecified——
N39.0 - Urinary tract infection, site not specified——
N93.9 - Abnormal uterine and vaginal bleeding, unspecified——
N98.3 - Complications of attempted introduction of embryo in embryo transfer——
O09 - Supervision of high risk pregnancy——
O09.0 - Supervision of pregnancy with history of infertility——
O09.11 - Supervision of pregnancy with history of ectopic pregnancy, first trimester——
O09.12 - Supervision of pregnancy with history of ectopic pregnancy, second trimester——
O09.13 - Supervision of pregnancy with history of ectopic pregnancy, third trimester——
O09.2 - Supervision of pregnancy with other poor reproductive or obstetric history——
O09.21 - Supervision of pregnancy with history of pre-term labor——
O09.3 - Supervision of pregnancy with insufficient antenatal care——
O09.30 - Supervision of pregnancy with insufficient antenatal care, unspecified trimester——
O09.31 - Supervision of pregnancy with insufficient antenatal care, first trimester——
O09.32 - Supervision of pregnancy with insufficient antenatal care, second trimester——
O09.33 - Supervision of pregnancy with insufficient antenatal care, third trimester——
O09.521 - Supervision of elderly multigravida, first trimester——
O10 - Pre-existing hypertension complicating pregnancy, childbirth and the puerperium——
O10.119 - Pre-existing hypertensive heart disease complicating pregnancy, unspecified trimester——
O10.23 - Pre-existing hypertensive chronic kidney disease complicating the puerperium——
O12 - Gestational [pregnancy-induced] edema and proteinuria without hypertension——
O12.0 - Gestational edema——
O12.20 - Gestational edema with proteinuria, unspecified trimester——
O14 - Pre-eclampsia——
O14.0 - Mild to moderate pre-eclampsia——
O14.1 - Severe pre-eclampsia——
O21.0 - Mild hyperemesis gravidarum——
O23.9 - Unspecified genitourinary tract infection in pregnancy——
O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester——
O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester——
O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester——
O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester——
O24 - Diabetes mellitus in pregnancy, childbirth, and the puerperium——
O24.410 - Gestational diabetes mellitus in pregnancy, diet controlled——
O24.414 - Gestational diabetes mellitus in pregnancy, insulin controlled——
O24.415 - Gestational diabetes mellitus in pregnancy, controlled by oral hypoglycemic drugs——
O26 - Maternal care for other conditions predominantly related to pregnancy——
O26.831 - Pregnancy related renal disease, first trimester——
O26.832 - Pregnancy related renal disease, second trimester——
O26.833 - Pregnancy related renal disease, third trimester——
O26.839 - Pregnancy related renal disease, unspecified trimester——
O28 - Abnormal findings on antenatal screening of mother——
O28.0 - Abnormal hematological finding on antenatal screening of mother——
O28.9 - Unspecified abnormal findings on antenatal screening of mother——
O35 - Maternal care for known or suspected fetal abnormality and damage——
O35.0 - Maternal care for (suspected) central nervous system malformation in fetus——
O36.01 - Maternal care for anti-D [Rh] antibodies——
O80 - Encounter for full-term uncomplicated delivery——
O86.2 - Urinary tract infection following delivery——
O98.41 - Viral hepatitis complicating pregnancy——
O98.411 - Viral hepatitis complicating pregnancy, first trimester——
O98.412 - Viral hepatitis complicating pregnancy, second trimester——
O98.413 - Viral hepatitis complicating pregnancy, third trimester——
O98.419 - Viral hepatitis complicating pregnancy, unspecified trimester——
O98.42 - Viral hepatitis complicating childbirth——
O98.7 - Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium——
O98.71 - Human immunodeficiency virus [HIV] disease complicating pregnancy——
O98.719 - Human immunodeficiency virus [HIV] disease complicating pregnancy, unspecified trimester——
O98.72 - Human immunodeficiency virus [HIV] disease complicating childbirth——
O98.73 - Human immunodeficiency virus [HIV] disease complicating the puerperium——
O99 - Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium——
O99.01 - Anemia complicating pregnancy——
O99.011 - Anemia complicating pregnancy, first trimester——
O99.012 - Anemia complicating pregnancy, second trimester——
O99.013 - Anemia complicating pregnancy, third trimester——
O99.119 - Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, unspecified trimester——
O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester——
O99.320 - Drug use complicating pregnancy, unspecified trimester——
O99.810 - Abnormal glucose complicating pregnancy——
O99.814 - Abnormal glucose complicating childbirth——
O99.830 - Other infection carrier state complicating pregnancy——
P09 - Abnormal findings on neonatal screening——
P35.3 - Congenital viral hepatitis——
P58 - Neonatal jaundice due to other excessive hemolysis——
P59 - Neonatal jaundice from other and unspecified causes——
P59.0 - Neonatal jaundice associated with preterm delivery——
P59.2 - Neonatal jaundice from other and unspecified hepatocellular damage——
P59.20 - Neonatal jaundice from unspecified hepatocellular damage——
P59.8 - Neonatal jaundice from other specified causes——
P59.9 - Neonatal jaundice, unspecified——
Q44.4 - Choledochal cyst——
Q44.6 - Cystic disease of liver——
Q61 - Cystic kidney disease——
Q61.19 - Other polycystic kidney, infantile type——
R00.0 - Tachycardia, unspecified——
R03.0 - Elevated blood-pressure reading, without diagnosis of hypertension——
R04 - Hemorrhage from respiratory passages——
R04.0 - Epistaxis——
R04.2 - Hemoptysis——
R05 - Cough——
R05.9 - Cough, unspecified——
R06.00 - Dyspnea, unspecified——
R06.02 - Shortness of breath——
R06.09 - Other forms of dyspnea——
R07 - Pain in throat and chest——
R07.1 - Chest pain on breathing——
R10 - Abdominal and pelvic pain——
R10.0 - Acute abdomen——
R10.10 - Upper abdominal pain, unspecified——
R10.11 - Right upper quadrant pain——
R10.12 - Left upper quadrant pain——
R10.2 - Pelvic and perineal pain——
R10.30 - Lower abdominal pain, unspecified——
R10.811 - Right upper quadrant abdominal tenderness——
R10.84 - Generalized abdominal pain——
R10.9 - Unspecified abdominal pain——
R11 - Nausea and vomiting——
R11.0 - Nausea——
R11.1 - Vomiting——
R11.10 - Vomiting, unspecified——
R11.11 - Vomiting without nausea——
R11.2 - Nausea with vomiting, unspecified——
R16 - Hepatomegaly and splenomegaly, not elsewhere classified——
R16.0 - Hepatomegaly, not elsewhere classified——
R16.1 - Splenomegaly, not elsewhere classified——
R16.2 - Hepatomegaly with splenomegaly, not elsewhere classified——
R17 - Unspecified jaundice——
R18 - Ascites——
R18.0 - Malignant ascites——
R18.8 - Other ascites——
R19 - Other symptoms and signs involving the digestive system and abdomen——
R19.0 - Intra-abdominal and pelvic swelling, mass and lump——
R19.00 - Intra-abdominal and pelvic swelling, mass and lump, unspecified site——
R19.5 - Other fecal abnormalities——
R19.7 - Diarrhea, unspecified——
R20.2 - Paresthesia of skin——
R21 - Rash and other nonspecific skin eruption——
R23 - Other skin changes——
R23.1 - Pallor——
R23.3 - Spontaneous ecchymoses——
R25.2 - Cramp and spasm——
R26 - Abnormalities of gait and mobility——
R26.9 - Unspecified abnormalities of gait and mobility——
R29.3 - Abnormal posture——
R31 - Hematuria——
R31.0 - Gross hematuria——
R31.1 - Benign essential microscopic hematuria——
R31.9 - Hematuria, unspecified——
R35 - Polyuria——
R35.0 - Frequency of micturition——
R39.15 - Urgency of urination——
R40.20 - Unspecified coma——
R41.0 - Disorientation, unspecified——
R41.82 - Altered mental status, unspecified——
R42 - Dizziness and giddiness——
R43.0 - Anosmia——
R50 - Fever of other and unknown origin——
R50.81 - Fever presenting with conditions classified elsewhere——
R50.9 - Fever, unspecified——
R51.9 - Headache, unspecified——
R53 - Malaise and fatigue——
R53.0 - Neoplastic (malignant) related fatigue——
R53.1 - Weakness——
R53.81 - Other malaise——
R53.83 - Other fatigue——
R56 - Convulsions, not elsewhere classified——
R56.9 - Unspecified convulsions——
R58 - Hemorrhage, not elsewhere classified——
R59 - Enlarged lymph nodes——
R59.0 - Localized enlarged lymph nodes——
R59.1 - Generalized enlarged lymph nodes——
R59.9 - Enlarged lymph nodes, unspecified——
R60 - Edema, not elsewhere classified——
R60.0 - Localized edema——
R60.9 - Edema, unspecified——
R61 - Generalized hyperhidrosis——
R63.4 - Abnormal weight loss——
R65.2 - Severe sepsis——
R68.83 - Chills (without fever)——
R68.89 - Other general symptoms and signs——
R70.0 - Elevated erythrocyte sedimentation rate——
R74 - Abnormal serum enzyme levels——
R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]——
R74.01 - Elevation of levels of liver transaminase levels——
R74.9 - Abnormal serum enzyme level, unspecified——
R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV]——
R76.8 - Other specified abnormal immunological findings in serum——
R77 - Other abnormalities of plasma proteins——
R77.9 - Abnormality of plasma protein, unspecified——
R78 - Findings of drugs and other substances, not normally found in blood——
R78.1 - Finding of opiate drug in blood——
R78.2 - Finding of cocaine in blood——
R78.4 - Finding of other drugs of addictive potential in blood——
R78.5 - Finding of other psychotropic drug in blood——
R79 - Other abnormal findings of blood chemistry——
R79.82 - Elevated C-reactive protein (CRP)——
R79.9 - Abnormal finding of blood chemistry, unspecified——
R80 - Proteinuria——
R80.0 - Isolated proteinuria——
R80.1 - Persistent proteinuria, unspecified——
R80.9 - Proteinuria, unspecified——
R82.1 - Myoglobinuria——
R82.3 - Hemoglobinuria——
R93.2 - Abnormal findings on diagnostic imaging of liver and biliary tract——
R94 - Abnormal results of function studies——
R94.4 - Abnormal results of kidney function studies——
R94.5 - Abnormal results of liver function studies——
R94.8 - Abnormal results of function studies of other organs and systems——
R97.1 - Elevated cancer antigen 125 [CA 125]——
T14.91XA - Suicide attempt, initial encounter——
T36.3X5A - Adverse effect of macrolides, initial encounter——
T36.4X5A - Adverse effect of tetracyclines, initial encounter——
T37.1X5A - Adverse effect of antimycobacterial drugs, initial encounter——
T38 - Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified——
T38.4X5A - Adverse effect of oral contraceptives, initial encounter——
T38.7X5A - Adverse effect of androgens and anabolic congeners, initial encounter——
T39 - Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics——
T39.013 - Poisoning by aspirin, assault——
T39.094S - Poisoning by salicylates, undetermined, sequela——
T39.1 - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives——
T39.1X1 - Poisoning by 4-Aminophenol derivatives, accidental (unintentional)——
T39.1X1A - Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter——
T39.1X2 - Poisoning by 4-Aminophenol derivatives, intentional self-harm——
T39.1X2A - Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter——
T39.1X3 - Poisoning by 4-Aminophenol derivatives, assault——
T39.1X3A - Poisoning by 4-Aminophenol derivatives, assault, initial encounter——
T39.1X4 - Poisoning by 4-Aminophenol derivatives, undetermined——
T39.1X4A - Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter——
T40 - Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]——
T40.0 - Poisoning by, adverse effect of and underdosing of opium——
T40.0X - Poisoning by, adverse effect of and underdosing of opium——
T40.0X1 - Poisoning by opium, accidental (unintentional)——
T40.0X1A - Poisoning by opium, accidental (unintentional), initial encounter——
T40.0X1D - Poisoning by opium, accidental (unintentional), subsequent encounter——
T40.0X1S - Poisoning by opium, accidental (unintentional), sequela——
T40.0X2 - Poisoning by opium, intentional self-harm——
T40.0X2A - Poisoning by opium, intentional self-harm, initial encounter——
T40.0X2D - Poisoning by opium, intentional self-harm, subsequent encounter——
T40.0X2S - Poisoning by opium, intentional self-harm, sequela——
T40.0X3 - Poisoning by opium, assault——
T40.0X5 - Adverse effect of opium——
T40.1X1A - Poisoning by heroin, accidental (unintentional), initial encounter——
T40.2X4 - Poisoning by other opioids, undetermined——
T40.2X4A - Poisoning by other opioids, undetermined, initial encounter——
T40.2X4D - Poisoning by other opioids, undetermined, subsequent encounter——
T40.2X4S - Poisoning by other opioids, undetermined, sequela——
T40.2X5 - Adverse effect of other opioids——
T40.2X5A - Adverse effect of other opioids, initial encounter——
T40.2X5D - Adverse effect of other opioids, subsequent encounter——
T40.2X5S - Adverse effect of other opioids, sequela——
T40.2X6 - Underdosing of other opioids——
T40.2X6A - Underdosing of other opioids, initial encounter——
T40.2X6D - Underdosing of other opioids, subsequent encounter——
T42 - Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs——
T42.2 - Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones——
T42.3X1A - Poisoning by barbiturates, accidental (unintentional), initial encounter——
T42.3X1D - Poisoning by barbiturates, accidental (unintentional), subsequent encounter——
T42.3X3A - Poisoning by barbiturates, assault, initial encounter——
T42.3X3D - Poisoning by barbiturates, assault, subsequent encounter——
T42.3X3S - Poisoning by barbiturates, assault, sequela——
T42.3X5A - Adverse effect of barbiturates, initial encounter——
T42.4X2A - Poisoning by benzodiazepines, intentional self-harm, initial encounter——
T42.4X2D - Poisoning by benzodiazepines, intentional self-harm, subsequent encounter——
T42.4X2S - Poisoning by benzodiazepines, intentional self-harm, sequela——
T42.4X5A - Adverse effect of benzodiazepines, initial encounter——
T43.3X5A - Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter——
T45.1X5A - Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter——
T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter——
T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter——
T50.901A - Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter——
T51 - Toxic effect of alcohol——
T51.9 - Toxic effect of unspecified alcohol——
T86 - Complications of transplanted organs and tissue——
T86.10 - Unspecified complication of kidney transplant——
T86.11 - Kidney transplant rejection——
T86.12 - Kidney transplant failure——
T86.4 - Complications of liver transplant——
T86.40 - Unspecified complication of liver transplant——
T86.41 - Liver transplant rejection——
T86.42 - Liver transplant failure——
T86.43 - Liver transplant infection——
T86.49 - Other complications of liver transplant——
T86.890 - Other transplanted tissue rejection——
T86.891 - Other transplanted tissue failure——
Z00 - Encounter for general examination without complaint, suspected or reported diagnosis——
Z00.0 - Encounter for general adult medical examination——
Z00.00 - Encounter for general adult medical examination without abnormal findings——
Z00.01 - Encounter for general adult medical examination with abnormal findings——
Z00.8 - Encounter for other general examination——
Z01.00 - Encounter for examination of eyes and vision without abnormal findings——
Z01.110 - Encounter for hearing examination following failed hearing screening——
Z01.30 - Encounter for examination of blood pressure without abnormal findings——
Z01.31 - Encounter for examination of blood pressure with abnormal findings——
Z01.41 - Encounter for routine gynecological examination——
Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings——
Z01.419 - Encounter for gynecological examination (general) (routine) without abnormal findings——
Z01.8 - Encounter for other specified special examinations——
Z01.81 - Encounter for preprocedural examinations——
Z01.810 - Encounter for preprocedural cardiovascular examination——
Z01.811 - Encounter for preprocedural respiratory examination——
Z01.812 - Encounter for preprocedural laboratory examination——
Z01.818 - Encounter for other preprocedural examination——
Z01.82 - Encounter for allergy testing——
Z01.83 - Encounter for blood typing——
Z01.84 - Encounter for antibody response examination——
Z02 - Encounter for administrative examination——
Z04 - Encounter for examination and observation for other reasons——
Z11 - Encounter for screening for infectious and parasitic diseases——
Z11.0 - Encounter for screening for intestinal infectious diseases——
Z11.1 - Encounter for screening for respiratory tuberculosis——
Z11.2 - Encounter for screening for other bacterial diseases——
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission——
Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]——
Z11.5 - Encounter for screening for other viral diseases——
Z11.51 - Encounter for screening for human papillomavirus (HPV)——
Z11.52 - Encounter for screening for COVID-19——
Z11.59 - Encounter for screening for other viral diseases——
Z11.7 - Encounter for testing for latent tuberculosis infection——
Z12 - Encounter for screening for malignant neoplasms——
Z12.10 - Encounter for screening for malignant neoplasm of intestinal tract, unspecified——
Z12.11 - Encounter for screening for malignant neoplasm of colon——
Z12.2 - Encounter for screening for malignant neoplasm of respiratory organs——
Z12.31 - Encounter for screening mammogram for malignant neoplasm of breast——
Z12.39 - Encounter for other screening for malignant neoplasm of breast——
Z12.4 - Encounter for screening for malignant neoplasm of cervix——
Z12.5 - Encounter for screening for malignant neoplasm of prostate——
Z12.6 - Encounter for screening for malignant neoplasm of bladder——
Z12.72 - Encounter for screening for malignant neoplasm of vagina——
Z12.73 - Encounter for screening for malignant neoplasm of ovary——
Z12.83 - Encounter for screening for malignant neoplasm of skin——
Z12.89 - Encounter for screening for malignant neoplasm of other sites——
Z13 - Encounter for screening for other diseases and disorders——
Z13.0 - Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism——
Z13.1 - Encounter for screening for diabetes mellitus——
Z13.22 - Encounter for screening for metabolic disorder——
Z13.220 - Encounter for screening for lipoid disorders——
Z13.228 - Encounter for screening for other metabolic disorders——
Z13.29 - Encounter for screening for other suspected endocrine disorder——
Z13.30 - Encounter for screening examination for mental health and behavioral disorders, unspecified——
Z13.31 - Encounter for screening for depression——
Z13.39 - Encounter for screening examination for other mental health and behavioral disorders——
Z13.40 - Encounter for screening for unspecified developmental delays——
Z13.41 - Encounter for autism screening——
Z13.42 - Encounter for screening for global developmental delays (milestones)——
Z13.5 - Encounter for screening for eye and ear disorders——
Z13.6 - Encounter for screening for cardiovascular disorders——
Z13.810 - Encounter for screening for upper gastrointestinal disorder——
Z13.811 - Encounter for screening for lower gastrointestinal disorder——
Z13.820 - Encounter for screening for osteoporosis——
Z13.828 - Encounter for screening for other musculoskeletal disorder——
Z13.83 - Encounter for screening for respiratory disorder NEC——
Z13.850 - Encounter for screening for traumatic brain injury——
Z13.858 - Encounter for screening for other nervous system disorders——
Z13.88 - Encounter for screening for disorder due to exposure to contaminants——
Z13.89 - Encounter for screening for other disorder——
Z13.9 - Encounter for screening, unspecified——
Z15.89 - Genetic susceptibility to other disease——
Z16 - Resistance to antimicrobial drugs——
Z16.33 - Resistance to antiviral drug(s)——
Z16.341 - Resistance to single antimycobacterial drug——
Z20 - Contact with and (suspected) exposure to communicable diseases——
Z20.5 - Contact with and (suspected) exposure to viral hepatitis——
Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV]——
Z21 - Asymptomatic human immunodeficiency virus [HIV] infection status——
Z22.5 - ——
Z22.50 - ——
Z22.51 - ——
Z22.52 - ——
Z22.59 - ——
Z30.014 - Encounter for initial prescription of intrauterine contraceptive device——
Z30.8 - Encounter for other contraceptive management——
Z31.430 - Encounter of female for testing for genetic disease carrier status for procreative management——
Z31.440 - Encounter of male for testing for genetic disease carrier status for procreative management——
Z31.441 - Encounter for testing of male partner of patient with recurrent pregnancy loss——
Z32.0 - Encounter for pregnancy test——
Z33 - Pregnant state——
Z34 - Encounter for supervision of normal pregnancy——
Z34.0 - Encounter for supervision of normal first pregnancy——
Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester——
Z34.01 - Encounter for supervision of normal first pregnancy, first trimester——
Z34.02 - Encounter for supervision of normal first pregnancy, second trimester——
Z34.03 - Encounter for supervision of normal first pregnancy, third trimester——
Z34.8 - Encounter for supervision of other normal pregnancy——
Z34.80 - Encounter for supervision of other normal pregnancy, unspecified trimester——
Z34.81 - Encounter for supervision of other normal pregnancy, first trimester——
Z34.82 - Encounter for supervision of other normal pregnancy, second trimester——
Z34.83 - Encounter for supervision of other normal pregnancy, third trimester——
Z34.9 - Encounter for supervision of normal pregnancy, unspecified——
Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester——
Z34.91 - Encounter for supervision of normal pregnancy, unspecified, first trimester——
Z34.92 - Encounter for supervision of normal pregnancy, unspecified, second trimester——
Z34.93 - Encounter for supervision of normal pregnancy, unspecified, third trimester——
Z36 - Encounter for antenatal screening of mother——
Z36.0 - Encounter for antenatal screening for chromosomal anomalies——
Z36.1 - Encounter for antenatal screening for raised alphafetoprotein level——
Z36.2 - Encounter for other antenatal screening follow-up——
Z36.4 - Encounter for antenatal screening for fetal growth retardation——
Z36.8 - Encounter for other antenatal screening——
Z36.89 - Encounter for other specified antenatal screening——
Z36.9 - Encounter for antenatal screening, unspecified——
Z39.0 - Encounter for care and examination of mother immediately after delivery——
Z48.23 - Encounter for aftercare following liver transplant——
Z51 - Encounter for other aftercare and medical care——
Z51.0 - Encounter for antineoplastic radiation therapy——
Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy——
Z51.11 - Encounter for antineoplastic chemotherapy——
Z51.12 - Encounter for antineoplastic immunotherapy——
Z51.81 - Encounter for therapeutic drug level monitoring——
Z63.72 - Alcoholism and drug addiction in family——
Z67 - Blood type——
Z68 - Body mass index [BMI]——
Z71.4 - Alcohol abuse counseling and surveillance——
Z71.41 - Alcohol abuse counseling and surveillance of alcoholic——
Z71.42 - Counseling for family member of alcoholic——
Z71.5 - Drug abuse counseling and surveillance——
Z71.51 - Drug abuse counseling and surveillance of drug abuser——
Z71.52 - Counseling for family member of drug abuser——
Z76.82 - Awaiting organ transplant status——
Z77 - Other contact with and (suspected) exposures hazardous to health——
Z77.120 - Contact with and (suspected) exposure to mold (toxic)——
Z77.21 - Contact with and (suspected) exposure to potentially hazardous body fluids——
Z79 - Long term (current) drug therapy——
Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)——
Z79.3 - Long term (current) use of hormonal contraceptives——
Z79.52 - Long term (current) use of systemic steroids——
Z79.620 - Long term (current) use of immunosuppressive biologic——
Z79.84 - Long term (current) use of oral hypoglycemic drugs——
Z79.89 - Other long term (current) drug therapy——
Z79.890 - Hormone replacement therapy——
Z79.891 - Long term (current) use of opiate analgesic——
Z79.899 - Other long term (current) drug therapy——
Z80 - Family history of primary malignant neoplasm——
Z80.7 - Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues——
Z80.9 - Family history of malignant neoplasm, unspecified——
Z81 - Family history of mental and behavioral disorders——
Z81.1 - Family history of alcohol abuse and dependence——
Z81.3 - Family history of other psychoactive substance abuse and dependence——
Z81.4 - Family history of other substance abuse and dependence——
Z82.61 - Family history of arthritis——
Z83.0 - Family history of human immunodeficiency virus [HIV] disease——
Z83.79 - Family history of other diseases of the digestive system——
Z84 - Family history of other conditions——
Z84.1 - Family history of disorders of kidney and ureter——
Z85 - Personal history of malignant neoplasm——
Z85.05 - Personal history of malignant neoplasm of liver——
Z85.09 - Personal history of malignant neoplasm of other digestive organs——
Z85.7 - Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues——
Z85.71 - Personal history of Hodgkin lymphoma——
Z85.72 - Personal history of non-Hodgkin lymphomas——
Z85.79 - Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues——
Z86.11 - Personal history of tuberculosis——
Z86.19 - Personal history of other infectious and parasitic diseases——
Z86.39 - Personal history of other endocrine, nutritional and metabolic disease——
Z86.59 - Personal history of other mental and behavioral disorders——
Z86.79 - Personal history of other diseases of the circulatory system——
Z87.39 - Personal history of other diseases of the musculoskeletal system and connective tissue——
Z87.441 - Personal history of nephrotic syndrome——
Z87.59 - Personal history of other complications of pregnancy, childbirth and the puerperium——
Z87.798 - Personal history of other (corrected) congenital malformations——
Z87.898 - Personal history of other specified conditions——
Z91.190 - Patient's noncompliance with other medical treatment and regimen due to financial hardship——
Z91.198 - Patient's noncompliance with other medical treatment and regimen for other reason——
Z91.199 - Patient's noncompliance with other medical treatment and regimen due to unspecified reason——
Z94.0 - Kidney transplant status——
Z94.4 - Liver transplant status——
Z94.81 - Bone marrow transplant status——
Z94.84 - Stem cells transplant status——
Z99.2 - Dependence on renal dialysis——